PharmaLink Welcomes Growth Investment from WestView Capital Partners

July 21, 2025

Largo, Florida and Boston, Massachusetts – PharmaLink, a leading pharmaceutical reverse logistics platform, announced today that it has received a growth investment from WestView Capital Partners, a Boston-based growth equity firm focused on middle market growth companies.

Headquartered in Largo, Florida, PharmaLink is a leading pharmaceutical reverse logistics platform, serving as a centralized hub for the processing of unsaleable, expired, and recalled pharmaceutical products. Leveraging its unique position within the healthcare supply chain, PharmaLink supports pharmacies, hospitals, wholesalers, and manufacturers in efficiently managing product returns and refunds while ensuring full compliance with federal and state regulations. Its comprehensive suite of services includes product pickup and shipping, return and recall processing, credit reporting, reconciliation, regulatory documentation, and environmentally compliant disposal. PharmaLink’s intuitive user interface is backed by a powerful infrastructure that drives accurate processing and delivers real-time data with actionable analytics. In May, the Company announced a 50,000-square-foot expansion of its flagship operations center, more than doubling its processing capacity to meet rising demand across the pharmaceutical supply chain. This expanded footprint will pave the way for cutting-edge automation going live later this year – driving greater compliance, efficiency, and sustainability while ensuring scalable capacity for continued growth.

“Our partnership with WestView marks an exciting step forward for PharmaLink as we continue to deliver premium reverse logistics solutions to our clients,” said Thierry Beckers, President & CEO of PharmaLink. “We’ve consistently invested back into PharmaLink to scale our operations and meet the evolving needs of our customers. We selected WestView because we believe they share our long-term vision and bring the strategic insight and partnership needed to help guide our next phase of growth.”

“We’re thrilled to be partnering with Thierry, Adam Bottie (SVP of Strategic Development & Revenue), and the rest of the fantastic team at PharmaLink to support the continued expansion and enhancement of their service capabilities,” said Jeff Clark, Principal at WestView Capital Partners. “PharmaLink represents a great combination of WestView’s experience in both pharma services and distribution / logistics companies.”

Added Tom Gilligan, Vice President at WestView, “As the leading independent reverse logistics platform, PharmaLink has achieved impressive growth by delivering critical services to key constituents across the healthcare supply chain. We look forward to being part of their next chapter.”

PharmaLink was advised by Raymond James and represented by Johnson, Pope, Bokor, Ruppel & Burns, LLP, while WestView was represented by Latham & Watkins LLP. PharmaLink is WestView's tenth investment from WestView's Fund V, which it started investing in June 2023.

About PharmaLink

PharmaLink is the premier pharmaceutical reverse distributor, serving as a centralized hub for the processing of unsaleable pharmaceutical products. With services spanning the complete spectrum of the pharmaceutical supply chain, PharmaLink has a 360-degree view of the needs of all businesses involved in the delivery of healthcare. With customizable solutions available for any size client, PharmaLink is the choice provider for pharmaceutical return, recall, and disposal solutions for dispensers, wholesalers and manufacturers. For more information, please visit pharmalinkinc.com.

About WestView Capital Partners

WestView Capital Partners, a Boston-based growth equity firm focused exclusively on middle market growth companies, manages $2.7 billion in capital across five funds. WestView partners with existing management teams to sponsor minority and majority recapitalizations, growth, and consolidation transactions in several sectors, including healthcare technology and outsourcing, business services, software and IT services, and growth industrial. For more information, please visit wvcapital.com.